Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
11 hedge funds and large institutions have $1.81M invested in Vaccinex, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
8% less funds holding
Funds holding: 12 → 11 (-1)
24% less capital invested
Capital invested by funds: $2.39M → $1.81M (-$583K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$305K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.69K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$48 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$308K |
| 2 |
TC
Tacita Capital
Toronto,
Ontario, Canada
|
-$1.69K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$748 |
| 4 |
CAL
Capital Advisors Ltd
Shaker Heights,
Ohio
|
-$60 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$36 |
VCNX Hedge Fund Activity: Q2 2024 in Review
11 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q2 2024, worth a combined $1.81M — down 24% from $2.39M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VCNX and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was AIGH Capital Management, adding an estimated $305K. The largest seller was Armistice Capital, cutting an estimated $308K.
- 11 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q2 2024, down from 12 in Q1 2024.
- Funds reported $1.81M of Vaccinex, Inc. Common Stock stock for Q2 2024, down 24% quarter-over-quarter.
- 1 fund opened new Vaccinex, Inc. Common Stock positions in Q2 2024 and 2 closed out, a net change of -1 holder.
- The largest Vaccinex, Inc. Common Stock buyer in Q2 2024 was AIGH Capital Management, an estimated $305K added.
- The largest Vaccinex, Inc. Common Stock seller in Q2 2024 was Armistice Capital, an estimated $308K sold.
Based on aggregated 13F filings for Q2 2024.